欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1330/001
药品名称Etoposide Accord
活性成分
    • etoposide 20.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare B.V. Winthontlaan 200 Utrecht Netherlands
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
      Etoposide Accoard 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Belgium (BE)
      Etoposide Accord Healthcare 20 mg/ml, Concentraat voor oplossing voor infusie
    • Netherlands (NL)
      Etoposide Accord 20 mg/ml, concentraat voor oplossing voor infusie
    • Iceland (IS)
      Etópósíð Accord 20 mg/ml Innrennslisþykkni, lausn
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Etoposid Accord 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Norway (NO)
      Etoposide Accord
    • Finland (FI)
    • Poland (PL)
      Etopozyd Accord
    • Latvia (LV)
      Etoposide Accord 20 mg/ml koncentrāts infūziju šķīduma pagatavošanai
    • Lithuania (LT)
      Etoposide Accord 20 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
      ETOPOSIDE ACCORD 20 MG/ML
    • Hungary (HU)
      ETOPOSIDE ACCORD 20 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Etoposide Accord
    • Cyprus (CY)
      ETOPOSIDE ACCORD CON FOR SOL FOR INFUSION
    • Czechia (CZ)
      Etoposide Accord 20 mg/ml koncentrát pro infuzní roztok
    • Romania (RO)
      Etoposid Accord 20 mg/ml Concentrat pentru soluţie perfuzabilă
    • Slovakia (SK)
      Etoposide Accord
    • Slovenia (SI)
    • Luxembourg (LU)
    • France (FR)
许可日期2014/04/29
最近更新日期2024/04/26
药物ATC编码
    • L01CB01 etoposide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase